Loading…
Feasibility/Acceptability of an Acceptance-Based Therapy Intervention for Diverse Adolescent Cisgender Girls With Overweight/Obesity
This study assessed the feasibility and acceptability of an ABT healthy lifestyle intervention among diverse adolescent cisgender girls with overweight/obesity (OW/OB). Adolescent cisgender girls ages 14 to 19 with a BMI ≥ 85th percentile-for-sex-and-age were recruited for participation in a single-...
Saved in:
Published in: | Current developments in nutrition 2021-06, Vol.5 (Supplement_2), p.1201-1201 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This study assessed the feasibility and acceptability of an ABT healthy lifestyle intervention among diverse adolescent cisgender girls with overweight/obesity (OW/OB).
Adolescent cisgender girls ages 14 to 19 with a BMI ≥ 85th percentile-for-sex-and-age were recruited for participation in a single-arm feasibility study. The primary outcomes were recruitment and retention while the secondary outcome was change in BMI Z-score over the 6-month intervention. Exploratory outcomes included obesity-related factors, health-related behaviors, and psychological factors.
Recruitment goals were achieved; thirteen adolescents (>60% racial/ethnic minorities) participated in the intervention, and eleven completed the intervention (85% retention). In completers (n = 11), a mean decrease in BMI Z-score of –0.15 (SD = 0.34, Cohen’s d = –0.44) was observed. Improvements were also noted for change in percentage of 95th percentile (d = –0.35), % body fat (d = –0.35), quality of life (d = 0.71), psychological flexibility (d = –0.86), and depression (d = –0.86).
These preliminary findings suggest an ABT healthy lifestyle intervention tailored for adolescent cisgender girls with OW/OB may be an acceptable treatment that could lead to improvements in BMI Z-score, obesity-related measures, and psychological outcomes.
This work is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH; UL1TR001427) and WellCare Health Plans, Inc. Dr. Cardel is also supported by the National Institutes of Health National Heart, Lung, and Blood Institute (K01HL141535 and R25HL126146). |
---|---|
ISSN: | 2475-2991 2475-2991 |
DOI: | 10.1093/cdn/nzab055_011 |